Expression of β-F1-ATPase and mitochondrial transcription factor A and the change in mitochondrial DNA content in colorectal cancer: clinical data analysis and evidence from an in vitro study

International Journal of Colorectal Disease

Volumn 23, Issue 12, 2008, Pages 1223-1232

  Lin, Pei Ching ^a   Lin, Jen Kou ^b   Yang, Shung Haur ^b   Wang, Huann Sheng ^b   Li, Anna Fen Yau ^b   Chang, Shih Ching ^b  

^a TAIPEI CITY HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

F1 ATPase; Colorectal cancer; Hypoxia; Mitochondria; Prognosis

Indexed keywords

ADENOSINE TRIPHOSPHATASE; FLUOROURACIL; MITOCHONDRIAL DNA; MITOCHONDRIAL TRANSCRIPTION FACTOR A; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CELL CULTURE; COLORECTAL CANCER; DISEASE FREE SURVIVAL; DISORDERS OF MITOCHONDRIAL FUNCTIONS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXIA; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; MITOCHONDRION; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TUMOR LOCALIZATION;

BLOTTING, WESTERN; CELL HYPOXIA; COLORECTAL NEOPLASMS; DNA, MITOCHONDRIAL; DNA-BINDING PROTEINS; FEMALE; FLOW CYTOMETRY; FLUOROURACIL; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MITOCHONDRIAL PROTEINS; MITOCHONDRIAL PROTON-TRANSLOCATING ATPASES; PROGNOSIS; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 56749091977     PISSN: 01791958     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00384-008-0539-4     Document Type: Article

References (48)

1. Green DR, Reed JC (1998) Mitochondria and apoptosis. Science 281:1309-1312
2. Ferri KF, Kroemer G (2001) Organelle-specific initiation of cell death pathways. Nat Cell Biol 3:E255-E263
3. Wang X (2001) The expanding role of mitochondria in apoptosis. Genes Dev 15:2922-2933
4. Jacobson MD, Weil M, Raff MC (1997) Programmed cell death in animal development. Cell 88:347-354
5. Thompson CB (1995) Apoptosis in the pathogenesis and treatment of disease. Science 267:1456-1462
6. Reed JC (1998) Mechanisms of apoptosis avoidance in cancer. Curr Opin Oncol 11:68-75
7. Warburg O (1956) On the origin of cancer cells. Science 123:309-314
8. Fliss MS, Usadel H, Caballero OL et al (2000) Facile detection of mitochondrial DNA mutations in tumors and bodily fluids. Science 287:2017-2019
9. Liu VW, Shi HH, Cheung AN et al (2001) High incidence of somatic mitochondrial DNA mutations in human ovarian carcinomas. Cancer Res 61:5998-6001
10. Parrella P, Xiao Y, Fliss M (2001) Detection of mitochondrial DNA mutations in primary breast cancer and fine-needle aspirates. Cancer Res 61:7623-7626
11. Kumimoto H, Yamane Y, Nishimoto Y et al (2004) Frequent somatic mutations of mitochondrial DNA in esophageal squamous cell carcinoma. Int J Cancer 108:228-231
12. Cuezva JM, Krajewska M, de Heredia ML et al (2002) The bioenergetic signature of cancer: A marker of tumor progression. Cancer Res 62:6674-6681
13. Ramanathan A, Wang C, Schreiber SL (2005) Perturbational profiling of a cell-line model of tumorigenesis by using metabolic measurements. Proc Natl Acad Sci U S A 102:5992-5997
14. Dey R, Moraes CT (2000) Lack of oxidative phosphorylation and low mitochondrial membrane potential decrease susceptibility to apoptosis and do not modulate the protective effect of Bcl-x(L) in osteosarcoma cells. J Biol Chem 275:7087-7094
15. Kim JY, Kim YH, Chang I et al (2002) Resistance of mitochondrial DNA-deficient cells to TRAIL: Role of Bax in TRAIL-induced apoptosis. Oncogene 21:3139-3148
16. Santamaria G, Martinez-Diez M, Fabregat I, Cuezva JM (2006) Efficient execution of cell death in non-glycolytic cells requires the generation of ROS controlled by the activity of mitochondrial H+-ATP synthase. Carcinogenesis 27:925-935
17. Vaupel P, Thews O, Kelleher DK, Hoeckel M (1998) Oxygenation of human tumors: The Mainz experience. Strahlenther Onkol 174:6-12
18. Vaupel P, Fortmeyer HP, Runkel S, Kallinowski F (1987) Blood flow, oxygen consumption, and tissue oxygenation of human breast cancer xenografts in nude rats. Cancer Res 47:3496-3503
19. Walenta S, Wetterling M, Lehrke M et al (2000) High lactate levels predict likelihood of metastases, tumor recurrence, and restricted patient survival in human cervical cancers. Cancer Res 60:916-921
20. Hockel M, Schlenger K, Aral B et al (1996) Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res 56:4509-4515
21. Hockel M, Schlenger K, Hockel S, Vaupel P (1999) Hypoxic cervical cancers with low apoptotic index are highly aggressive. Cancer Res 59:4525-4528
22. Brizel DM, Scully SP, Harrelson JM et al (1996) Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Res 56:941-943
23. Gaspari M, Falkenberg M, Larsson NG, Gustafsson CM (2004) The mitochondrial RNA polymerase contributes critically to promoter specificity in mammalian cells. EMBO J 23:4606-4614
24. Sobin LH, Wittekind C (1997) UICC TNM classification of malignant tumors, 5th edn. Wiley-Liss, New York, pp 66-69
25. Compton CC, Fielding LP, Burgart LJ et al (2000) Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 124:979-994
26. Mambo E, Chatterjee A, Xing M et al (2005) Tumor-specific changes in mtDNA content in human cancer. Int J Cancer 116:920-924
27. Chang SC, Lin JK, Yang SH (2006) Relationship between genetic alterations and prognosis in sporadic colorectal cancer. Int J Cancer 118:1721-1727
28. Fuller KM, Duffy CF, Arriaga EA (2002) Determination of the cardiolipin content of individual mitochondria by capillary electrophoresis with laser-induced fluorescence detection. Electrophoresis 23:1571-1576
29. Simonnet H, Alazard N, Pfeiffer K (2002) Low mitochondrial respiratory chain content correlates with tumor aggressiveness in renal cell carcinoma. Carcinogenesis 23:759-768
30. Meierhofer D, Mayr JA, Foetschl U et al (2004) Decrease of mitochondrial DNA content and energy metabolism in renal cell carcinoma. Carcinogenesis 25:1005-1010
31. Yin PH, Lee HC, Chau GY (2004) Alteration of the copy number and deletion of mitochondrial DNA in human hepatocellular carcinoma. Br J Cancer 90:2390-2396
32. Lee HC, Yin PH, Lin JC (2005) Mitochondrial genome instability and mtDNA depletion in human cancers. Ann N Y Acad Sci 1042:109-122
33. Falkenberg M, Gaspari M, Rantanen A (2002) Mitochondrial transcription factors B1 and B2 activate transcription of human mtDNA. Nat Genet 31:289-294
34. Larsson NG, Wang J, Wilhelmsson H et al (1998) Mitochondrial transcription factor A is necessary for mtDNA maintenance and embryogenesis in mice. Nat Genet 18:231-236
35. Kim YH, Lee JH, Chun H (2002) Apoptosis and its correlation with proliferative activity in rectal cancer. J Surg Oncol 79:236-242
36. Lazaris AC, Davaris P, Nakopoulou L et al (1994) Correlation between immunohistochemical expression of proliferating cell nuclear antigen and flow cytometry parameters in colorectal neoplasia. Dis Colon Rectum 37:1083-1089
37. Walenta S, Snyder S, Haroon ZA (2001) Tissue gradients of energy metabolites mirror oxygen tension gradients in a rat mammary carcinoma model. Int J Radiat Oncol Biol Phys 51:840-848
38. Shin YK, Yoo BC, Chang HJ (2005) Down-regulation of mitochondrial F1F0-ATP synthase in human colon cancer cells with induced 5-fluorouracil resistance. Cancer Res 65:3162-3170
39. Shchepina LA, Pletjushkina OY, Avetisyan AV (2002) Oligomycin, inhibitor of the F0 part of H+-ATPsynthase, suppresses the TNF-induced apoptosis. Oncogene 21:8149-8157
40. Eguchi Y, Shimizu S, Tsujimoto Y (1997) Intracellular ATP levels determine cell death fate by apoptosis or necrosis. Cancer Res 57:1835-1840
41. Matsuyama S, Xu Q, Velours J, Reed JC (1998) The mitochondrial F0F1-ATPase proton pump is required for function of the proapoptotic protein Bax in yeast and mammalian cells. Mol Cell 1:327-336
42. Goldstein JC, Waterhouse NJ, Juin P (2000) The coordinate release of cytochrome c during apoptosis is rapid, complete and kinetically invariant. Nat Cell Biol 2:156-162
43. Williams KJ, Cowen RL, Stratford IJ (2001) Hypoxia and oxidative stress. Tumour hypoxia-therapeutic considerations. Breast Cancer Res 3:328-331
44. Brown JM (1999) The hypoxic cell: A target for selective cancer therapy - eighteenth Bruce F. Cain Memorial Award lecture. Cancer Res 59:5863-5870
45. Rofstad EK (2000) Microenvironment-induced cancer metastasis. Int J Radiat Biol 76:589-605
46. Petit PX, Lecoeur H, Zorn E et al (1995) Alterations in mitochondrial structure and function are early events of dexamethasone-induced thymocyte apoptosis. J Cell Biol 130:157-167
47. Petit PX, Zamzami N, Vayssiere JL, Mignotte B (1997) Implication of mitochondria in apoptosis. Mol Cell Biochem 174:185-188
48. Cavalli LR, Liang BC (1998) Mutagenesis, tumorigenicity, and apoptosis: are the mitochondria involved? Mutat Res 398:19-26